ArticleAlzheimer's research & therapy2021

Neuroprotection in early stages of Alzheimer's disease is promoted by transthyretin angiogenic properties.

Tiago Gião et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.